Company intelligence / Profile preview

Sederma

Le Perray-en-Yvelines, Île-de-France / Yvelines, Francesesderma.com ↗

Ownership: Private
Development stage: Other

Overview

Sederma develops and manufactures bioactive ingredients—primarily peptides and plant cell culture derivatives—for the global cosmetics industry. Its best-known product line includes Matrixyl peptides for anti-ageing applications. The company uses advanced biotechnology including synthetic biology to create sustainable cosmetic actives with proven efficacy through in vitro/ex vivo/in vivo testing. It does not develop pharmaceutical drugs or therapeutics.

Therapeutic areas: Dermatology
Modalities: PeptidesProteinsPlant cell culture-derived ingredientsSmall molecule cosmetic activesFermentation-derived ingredientsSynthetic biology-based moleculesBotanical extracts
Industry: Non-Drug Biotech

Partnerships

Alganelle (synthetic biology/microalgae partnership)

Beyond the preview

Go deeper on Sederma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sederma.

Explore the full profile